About
Technology
Issues
FAQ
Links
Official Page
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.